NCT07340853 2026-03-10
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
University of California, San Francisco
Phase 1 Recruiting
University of California, San Francisco
Carevive Systems, Inc.
University Hospital, Montpellier
Memorial Sloan Kettering Cancer Center